As the pharmaceutical industry grapples with geopolitical tensions, regulatory shifts, and technological disruption, the question of what constitutes a strong external partnership has never been more critical. We asked industry leaders across CDMOs, biotechs, and technology providers to share their
“CDMOs are partners with deep, extensive technical expertise that can be leveraged strategically—not just a restaurant where you pick from a menu.” Marta Kijanka, founder of MK Bioconsultancy, is a strategic project manager and CMC consultant who guides early-stage biotech
Tony Watson, Director of Procurement at Accord Healthcare, believes relationships are everything: “We spend our entire careers working on this network, but it can deliver so much more. If I could do one thing with CDMOs and our business support
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
